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Division of Nephrology, Lankenau Hospital, City Line and Lancaster Ave., Philadelphia, Pennsylvania, USA
Solute transport in continuous hemodialysis: A new treatment for acute
renal failure. A pumpless dialysis technique which combines continu-
ous convection and diffusion was studied in 15 critically ill acute renal
failure patients. Fluid identical in composition and purity to that used in
peritoneal dialysis was continuously circulated (single—pass) at 16.6
cc/mm through the dialysis compartment of a 0.43 m2 flat plate PAN
membrane dialyzer. Whole blood clearances for urea, creatinine and
phosphate averaged 25,3 4.4 cc/mm, 24.1 5.5cc/mm and 21.3 5.6
cc/mm, respectively. Over the range of blood flows studied (50 to 190
cc/mm) clearances of these solutes were independent of blood flow rate
but rather were determined by both dialysate flow rate and ultrafiltra-
tion rate. In contrast net fluxes of calcium and sodium were correlated
only with ultrafiltration rate. Bicarbonate loss was 0.52 0.11 mEq/min;
K balance varied with dialysate K; glucose uptake from dialysate
was 107 24.0 mg/mm. In fresh non-clotting dialyzers, mean ultrafil-
tration rate was 8.1 cc/mm. At QBi of70 to 190 cc/mm, dialysate and
blood solute equilibrate yielding a total clearance equal to the dialysate
outflow, or 25 cc/mm, that is, the sum of dialysate flow rate plus
ultrafiltration rate. In comparison to currently used continuous arteri-
ovenous hemofiltration (CAVH), the exceptionally—high solute clear-
ances obtained with continuous hemodialysis constitute a significant
improvement in continuous renal replacement therapy.
Continuous, renal replacement therapy has become an ac-
cepted method for treating acute renal failure in critically ill
patients with multiorgan failure who are hemodynamically
unstable. Continuous arteriovenous hemofiltration (CAVH), a
convection—based blood cleansing therapy, is the most popular
form of the continuous therapies [1—4]. Geronemus has pro-
posed, as an alternative to CAVH, a technique called "contin-
uous arteriovenous hemodialysis" (CAVHD). This method
combines both convection and diffusion to achieve higher urea
and creatinine clearances than those obtained with routine
CAVH [5, 6]. Subsequent to Geronemus' insightful report there
have been no clinical or laboratory studies reported. The
present study in critically ill patients provides data for the first
in depth description of the transport characteristics and capa-
bilities of this new dialysis technique. All of the clinically
important small molecular weight solutes were studied using a
high flux polyacrylonitrile (PAN) membrane. The results indi-
cate that slow, continuous arteriovenous hemodialysis yields
superior clearances and adequate fluid removal when compared
with standard, continuous artenovenous hemofiltration (CAVH)
and constitutes a major improvement in the technique of contin-
uous renal replacement therapy.
Methods
Patient material
Studies were performed on 15 critical—care patients with
acute renal failure. All were continuously monitored with
indwelling arterial lines and flow directed Swan—Ganz catheters
located in the pulmonary artery (Honeywell Electronics,
Pleasantville, New Jersey, USA). Clinical details are outlined in
Table 1. Duration of slow continuous hemodialysis ranged from
four hours to 30.5 days.
Technique
The circuitry used in slow continuous hemodialysis (CAVHD)
is depicted in Figure 1. An 0.43 m2, effective area polyacrylo-
nitrile parallel plate hemodialyzer (Hospal, AN69S; SCU/CAVH,
Hospal, East Brunswick, New Jersey, USA) was used without
a blood pump. Access was via Quinton—Scribner arm shunts or
preferably by percutaneous femoral artery and vein cannulation
with #8 French, MedComp catheters for CAVH use (Medical
Components, Harleysville, Pennsylvania, USA). The dialysate
fluid was commercially available 1.5% Dianeal peritoneal dial-
ysis fluid (Travenol Labs, Deerfield, Illinois, USA)', infused
into the dialysate compartment by a calibrated constant infu-
sion pump (Abbott/Shaw, North Chicago, Illinois, USA) set to
deliver 16.65 cc/mm (1 liter/hr) of dialysate. Dialysate flow was
countercurrent to blood flow. Potassium was added according
to clinical need. Anticoagulation for CAVHD was conducted as
in routine CAVH [4]. Spent dialysate was measured hourly.
The volume infused was subtracted from the volume drained
and recorded as the hourly ultrafiltration rate. A percentage of
the ultrafiltrate volume was returned to the patient as Ringer's
lactate in accordance with fluid volume needs.
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'Composition: Na 132, Ca 3.5, Mg 1.5, Cl 102, lactate 35 mFq/liter,
glucose 1300 mg%.
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Table 1. Patient data
UF rate for
Duration of entire trmt.
treatment period cc/mm
Name Age Sex Diagnoses hours mean SD
L.M. 80 M ARFa, AMIb, CHF, CVD, DM 77 3.4 3.3
H.A. 65 M AM1', CABGC, Sepsis, ARF 709 4.9 4.2
C.D.d 77 F Pulmonary edema due to hypertensive crisis, reno-
vascular disease with acute renal failure acute
thrombo embolism—left femoral artery
36 6.3 4.2
M.E. 69 F CABGC, renal artery senosis, post-op ARF 24 5.8 2.0
G.D. 74 M Hepatorenal syndrome, sepsis, bleeding esophageal
varices
48 3.3 2.1
F.C. 77 G CABGC, anemia, ARF, ischemic bowel 4 13.5 4.18
J.M. 81 M Ruptured abdominal aortic aneurysm, AMI', sepsis,
ARF
250 4.0 2.6
M.P. 65 F CABGC, ARFa, bronchitis 20 3.5 3.3
L.P. 66 F Mitral stenosis, post-op aortic stenosis, aortic insuf-
ficiency, abdominal ascites, ARFa, jaundice
240 6.3 3.6
M.W. 57 F Pulmonary edema with CHF, ARFa, hypertension 116 3.9 2.9
M.B. 75 M Aortic insufficiency, post-op cardiogenic shock 50 4.1 2.7
W.I.
R.W.
59
64
M
M
CABGC, ARFa, cardiogenic shock
CABG, ARFa, AMIb, cardiogenic shock
30
47
2.6 1.8
5.3 3.1
R.M. 65 M CHF, ARFa, sepsis, cardiogenic shock, ARDS 7 4.6 2.0
W.P. 69 M CABGC, ARFa, wound infection, sepsis 734 4.5 2.8
Mean SD 154 239 4.8 2.6
a Acute renal failureb Acute myocardial infarction
Coronary artery bypass graft surgeryd Thrombosis superficial femoral artery at access site
e Reversible leg ischemia due to femoral access
When hemodynamic stability was assured by a 20 minute
period of stable central monitoring, specimens were obtained as
follows: Blood was first drawn slowly from its exit point from
the dialyzer (CB0) and then immediately drawn slowly from its
entry point into the dialyzer (CBI); a 5 to 10 minute, stopwatch—
timed collection of spent dialysate and ultrafiltrate, was then
measured in a graduated cylinder and an aliquot removed (CD0).
Fluid was then aspirated from the dialysate bag for analysis
(CDI). Blood flow was measured by the bubble transit time
Dialysate clearance
[1]
Dialysis fluid
Vein
Dialysate
collection
bag
Slow continuous hemodialysis
technique, using an unfractured 0.5 cc bubble with triplicate
measurements using a stopwatch accurate to 0.01 second. Qp
(ultrafiltration rate) was measured as total dialysate collected,
QD0, over a stopwatch—timed interval (5 to 10 minutes), minus
dialysis infusion rate, QDI. Determinations of BUN, creatinine,
sodium, potassium, chloride, bicarbonate, calcium, phospho-
InfuDon
rus, total protein, albumin, glucose, hemoglobin, hematocrit
were performed on blood and dialysate using standard autoan-
alyzer techniques. Studies on all solutes were conducted during
the same experimental run. Clearance formulae were derived
from the solute mass balance across the dialyzer when both
diffusion and ultrafiltration were occurring, [7, 8, 11] (Appendix
for Glossary of terms).
Blood side clearance:
QBCBI — QBOCB0
Fig. 1. Schematic representation of circuitry for slow continuous KB = C
hemodialysis. Bi
Experimental Dialysate side clearance derived from the solute uptake into
dialysate equals:
[2]= QDOCDO
— QDICDI
CBI
If QD0 = QDI + QF and QF = net ultrafiltration flow rate then;
QDI(CDO — CDI) QFCDO
KD= + [2a]
CBI CBI
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For analytic purposes the three components of equation 2a are
represented as A, B, C (vide infra).
(A) = (B) + (C)
The term QDI(CDO — CD)ICBI (B) represents the diffusive
component KDd or that amount of clearance which would
occur, if ultraffitration were zero. The term QFCDO/CB (C)
shows the deviation from the purely diffusive case when there is
a convective component (KD). These terms are mathematical
statements of clearance and do not physically describe the
diffusive and convective transport processes.
This hemodialysis technique as used in this study is opera-
tionally unique in that dialysate flow rate QD is <<<than blood
flow QBI, and outgoing dialysate solute concentration CD0
equals incoming blood solute concentration CBI if there is no
clotting in the dialyzer. In the analysis of solute transport, the
fact that CD0 is equal to CB allows the diffusive (K) and the
convective (K) components to be computed as separate
components of total clearance or mass transfer. Justification for
this assertion rests on the valid application of the following
dialysis principles:(1). Under conditions of dialysate saturation or diffusion
equilibrium where C0 = CBI, diffusive transport or clearance
(B) will always be the one value which is the upper limiting
value for a given set of solute concentrations and volume flows.
In the case of clearance, the explicit upper limiting value is
numerically equal to the dialysate flow rate Qm where Qni is
>> QDI. As QBI falls below 75 cc/mm or QD approaches QBI
there are small progressive deviations from complete satura-
tion.
(2.) Total clearance (A) equals the sum of the net diffusion
process (B) plus the net convective process (C). Total clearance
can also be calculated from equation [2]. The dialysate inflow
QD1 is known and hence, diffusive clearance (B) is thereby
known. Since total clearance is also known (A), the convective
clearance (C) can be calculated (A = B + C). The clearances
reported here use equation [2a] (which is a substituted rear-
rangement of equation [2]) rather than equation [1] since, under
these conditions of slow dialysate flow, dialysate inflow and
outflow concentration differences are substantial and solute
distribution problems in whole blood are minimized.
Mass transfer of solute
Mass transfer from blood, JB:
JB = QBiCB (mass in) — QBOCB0 (mass out)
Mass transfer of solute into dialysate, J:
JD = JDd (diffusion) + J0 (convection)
JD QDI (CDO — CDi) + QFCD0 = QDOCDO — QDCDI
where QDO = QDI + QF. When dialysate concentration, CD is
greater than C1, (as in the case of glucose or diffusable
calcium), the diffusive term will be negative and, depending on
the magnitude of the convective component, JD or J could be
net negative indicating uptake into the blood. The reasoning
used in justifying the separate use of convective and diffusive
components in the calculation of mass transfer is the same
reasoning that was used in the clearance section, since the
product of clearance and solute concentration equals mass
transfer (per unit time).
Percent mass balance error (& MBE)
Mass transfer (or clearance) from blood, J, must equal mass
uptake or appearance in dialysate, JD. Deviation from the
theoretical ideal is defined herein as % MBE.
%MBE = (JB — JD)/((JB+JD)/2) x 100
Concentration conversions and corrections
[5]
Whole blood (CB) concentrations of urea, creatinine, and
phosphate were calculated from plasma measurements by:
CB = C, [(1 — hematocrit) + Het x K]
For CBI or Cr0, hematocrit was determined on blood flowing
into or out of the dialyzer. K, the erythrocyte to plasma, solute
equilibrium distribution coefficient for urea, is 0.859; for creat-
mine 0.731; and 0.50 for phosphate [9]. Diffusable calcium was
calculated as 0.6 x total serum calcium [10]. Plasma flow, QB X
(1 — hematocrit) and serum concentration of sodium and
potassium were used in computing sodium, calcium and potas-
sium mass transfer. QE, effective blood water flow (the distri-
bution space for dissolved unbound solutes) instead of bulk
blood flow, QB, was used in computing bicarbonate mass
transfer:
I hct
Qn = QB [F — - (Fp — FR RD) [6]
where F = fraction of water in plasma, FR = waterfraction in
red cells and RD =
[HC03] in red cell waterRD = 0.69. [11][HC03} in plasma water
Equation 6 computes the non-cellular water flow adjusted for
cellular water containing bicarbonate and corrects for the
presence of non-bicarbonate containing plasma proteins [11].
Blood specimens were centrifuged 30 to 90 minutes after
sampling.
Hydraulic calculations
[3] Net transmembrane pressure (mm Hg) was computed:
TMP = (PBI + PB)I2 + 0.74 x H + rcr — Onc. Pres. [7]
[4] (Appendix II discusses this formula further). The dialysate
effluent collection bag (Fig. 1) when placed below the dialyzer
creates a siphon effect or negative pressure equal in, mm of
mercury, to the product of 0.74 times its vertical distance in
centimeters ("H" in Fig. 1). Oncotic pressure (Onc. Pres.) is
computed from the total protein and albumin values of: (CB +
C00)/2 using the nomogram of ROstick, Bohler and Kramer
based on the formula of Landis and Pappenheimer [12]. Hydro-
static pressures of inlet and outlet blood streams, and inlet and
outlet dialysate streams, were measured with aneroid gauges
(calibrated against a mercury manometer) with attention to the
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Time, days of treatment
Fig. 2. Level of BUN in relation to duration of CAVHD treatment.
levels of air fluid interfaces [131. The dialysate outlet gauge was
used as a check on the computed negative pressure.
Effect of treatment time on dialyzer function
After initiating treatment with a fresh dialyzer, hourly ultra-
filtration rates were recorded to assess the effect of time on
ultrafiltration rate and, hence, convective clearance. "Mean"
ultrafiltration rates were calculated from the hourly ultrafiltra-
tion rates obtained for the entire treatment period. Using
equation [2], changes in total urea clearance over time were
measured in nine of the patients listed in Table 1 who survived
more than 24 hours.
This research was approved by the Lankenau Hospital Insti-
tutional Review Board. Informed consent was obtained. Data
calculations, graphic plotting and statistical calculations were
done on an IBM PC AT computer using Lotus Symphony and
Statgraphics software programs (± SD of the mean).
Results
Clinical effect of continuous arteriovenous hemodialysis
The effects of CAVHD on the levels of azotemia and serum
electrolytes are seen in Figure 2 and Table 2. BUN was main-
tained at 50 24 mg/dl. Serum electrolytes at the end of treatment
were within acceptable ranges. Mean treatment time was 159
hours. Although control of biochemical uremia was excellent,
only two of these 15 patients with multiorgan failure survived.
Mass transfer studies; percent mass balance error
Figure 3 is a summary of all the mass balances for urea,
creatinine, phosphorus, bicarbonate, sodium, and potassium.
The majority of mass balance errors beyond 15% were positive,
indicating that blood side values exceeded dialysate values
when large % MBE were encountered. This was most apparent
for phosphorus which has a very unequal erythrocyte to plasma
distribution. A 15% MBE in urea clearance is approximately 3.5
cc/mm.
Table 2. Laboratory data CAVHD (mean SD), N = 15
BUN mg%
Electrolytes mEq/liter
Na K CO2 Cl
Pre Rx
End Rx
P
76 27
50 24
<0.01
137 7.8
134 9.2
NS
4.4 0.7 22.3 4,7 98 4.9
4.3 0.6 20.0 3.7 98 7.8
NS NS NS
Fig. 3. Percent mass balance error. Each point is a single patient
study. An entire spectrum, that is, urea, creatinine, phosphorus,
bicarbonate, etc., was measured during a single study. Hence, Q,
QB0, QD, Quo, and QF were the same for a given spectrum of solutes.
Figures at the top of the column are percentages of studies falling within
10% MBE and 15% MBE (). Symbols are: (*) dialysate K conc.; (0)
10 to 12 mEq/liter; (A) 3 to 5 mEq/liter; (•)) 0 mEq/liter.
Clearances and mass transfer results
Solute mass transfer and clearance were plotted in relation to
the clinically relevant parameters of blood flow and ultrafiltra-
tion rate, with dialysate flow rate, QDI, being held constant.
Urea transport
Average urea clearance in whole blood was 23.8 5.0 cc/mm
and 25.3 4.4 cc/mm in dialysate (N 17). The relationships
of the components of urea clearance are shown in Figure 4 in
which total urea clearance and the corresponding convective
component of the same clearance study are plotted against
ultrafiltration rate (QF). Total clearance rises parallel with
increases in convective clearance. The slope of total urea
clearance versus QF is 1.116. The slope of the convective
clearance is 1.040. Diffusive clearance is the ordinate quantity
between the two regression lines. When QF is zero, total
clearance equals the diffusive component of 15.91 cc/mm,
which approximates the 16.65 cc/mm dialysate flow rate indi-
cating complete equilbration of blood with dialysate. To deter-
mine if diffusive clearance (CDO — CDI)/CBI is impacted by
ultrafiltration rate, urea diffusive clearance (defined as total
clearance minus convective clearance) is plotted against ultra-
filtration rate (Fig. 5). The slope of the regression equation is
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Fig. 4. Whole blood clearance versus ultrafiltration rate. Each total
clearance point (+) has its corresponding convective component (0)
plotted directly under it on the lower line. Each set of points represents
either an indvidual patient (12 points) or a repeat study on the same
patient done at lesat one day apart (5 points). One point (•) was not
included in the regression because of a very low QB and lack of
membrane equilibration. The distance between the lines QDI.
0.075 and is not statistically different from zero (t = 0.7315, P>
0.4), indicating that ultrafiltration (Qp) and diffusive clearance
are not interactive statistically in the domain studied. Urea
clearance based on urea uptake into dialysate in relation to
blood flow (Q) is shown in Figure 6. Total urea clearance is
independent of Q, from 50 cc/mm to 180 cc/mm but falls when
blood flow falls below 50 cc/mm. Figure 6 also shows the
calculated corresponding diffusional component of urea clear-
ance, KDd (Methods). Mean diffusive clearance was 16.53 cc
1.48 cc/mm. The statistical best fit regression line of diffusive
urea clearance versus dialyzer blood flow is — 8.71 + 1.66
In QBI (r 0.55, P < 0.01). As blood flow, QBI, increases from
75 cc/mm to 150 cc/mm diffusive clearance, KDd, increases only
1.1 cc/mm from 15.9 cc/mm to 17.0 cc/mm. Kod thus approxi-
mates the dialysate inflow of 16.6 cc/mm indicating complete
equilibration of blood with dialysate and also indicating that the
diffusive component is dialysate flow limited in this operating
range. Diffusive clearance declines below 16 cc/mm as QBi
declines below 75 ccfmin indicating incomplete dialysate satu-
ration with blood solute. In Figure 6 the difference between the
diffusive component and total clearance is the convective
component secondary to ultrafiltration. Thus, the variation in
total clearance versus QBI is largely determined by the variation
in ultrafiltration rate.
Creatinine
Creatinine clearance in relation to dialyzer inlet blood flow is
seen in Figure 7. The mean total creatinine clearance, 24.1
18
17
16 -
I
15-
14 -
13
5-
0
4 6 8 10 12 14
Ultrafiltration (Qf), cc/mm
Fig. 5. Urea diffusive clearance KDd versus ultrafiltration rate. The
slope 0.0759 is not significantly different from zero (P> 0.47) indicating
no impact of QF on diffusive clearance.
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Fig. 6. Urea clearance (+) versus dialyzer blood flow. The diffusive
component Kfld (0) is plotted directly under its corresponding total
clearance value. Regression line relating QBi to Kjj is KI,d = 8.71 + 1.66
ln QBI (r = 0.55; P < 0.01) Data points are as described in Figure 4.
5.5 cc/mm, is quantitatively similar to urea as is the relationship
of creatinine clearance to dialyzer blood flow. The diffusive
component, KDd, (mean 16.2 2.3) approximates dialysate
flow rate until approximately 80 cc/mm blood flow when K
begins to decline (data not shown).
Phosphate
Phosphate clearance averaged 21.3 5.6 ce/mm. The diffu-
sive component was 14.9 2.8 ce/mm (N = 8).
US •
U S
.
a
• K 0.0759Qf + 16.14
r = 0.19
P> 0.47
+
+ + +÷ +
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U
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Fig. 7. Creatinine clearance versus blood flow. Eleven data points
represent individual patients, three data points are repeat studies.
Bicarbonate
Total dialysate side clearance KDHCO3 as a function of blood
water flow QE is seen in Figure 8. Clearance is independent of
blood water flow in the range of 70 to 180 cc/mm but falls off
sharply below 45 cc/mm. The diffusive component (not shown)
KDHCO3(d) was relatively constant over this blood—water flow
range, averaging 15.9 cc/mm and similar to the dialysate flow
rate of 16.6 cc/mm, indicating complete equilibration with
dialysate. Mean HC03 mass transfer was 0.52 mEq/min.
Assuming a relatively stable blood—level, a patient could lose
748 mEq of bicarbonate per day which must be replaced in part
by dialysate lactate.
Sodium
Mass transfer of sodium is determined primarily by convec-
tive transport. Figure 9 shows the regression of convective
sodium mass transfer JDNa(c) in relation to ultrafiltration rate,
QF. Also plotted is the regression of total mass transfer,
(diffusion and convection), JDNa versus QF. The virtual super-
imposition of the two regression lines of total transport and
convective transport indicates that total sodium transport is
mediated almost entirely by convection. The minimal difference
between the two lines represents that transport due to diffusion
(from B to D), a result of the slightly lower dialysate sodium
concentration. Average sodium loss was 1.18 mEq/min. or a
potential 1700 mEq sodium loss/day, some portion of which
must be replaced depending on the clinical status.
Potassium
The mass balance plot of blood side removal versus dialysate
uptake in Figure 3 shows good agreement when dialysate
potassium concentration is either 0 or 3 to 5 mEq/liter. When
bath potassium is 10 to 12 mEq/liter there is net uptake into
blood (negative JDK*). Mass transfer of K from blood to bath
when bath concentration is zero, averaged 0.09 mEq/min or 129
I I I I I I I I
0 20 40 60 80 100 120 140 160 180
QE. cc/mm
Fig. 8. Bicarbonate clearance versus effective blood water flow QEi.
2
1.8 -
1.6 -
1.4
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Ultrafiltration rate, Q
cc/mm
Fig. 9. Sodium flux .JDNO; total (+) and convective (0) components
versus ultrafiltration rate. Mean plasma sodium concentration for the
data presented was 137 mEq/liter (range 125 to 161 mEq/liter).
mEq/day lost. When bath K equals 3 to 5 mEq/liter, K loss is
0.04 mEq/min or 57 mEq/day.
Calcium
The dialysate calcium of 7 mg% favors diffusion of calcium
from bath to blood, which is opposed by convective transport in
the opposite direction from blood to bath. Because of the high
convective permeability of the membrane, net calcium flux is
determined by ultrafiltration, as is the case with sodium. Figure
10 shows the relation of total net transport JDCa which is from
blood to dialysate despite the higher dialysate ionized calcium.
The convective component JDCa(C) is also plotted against QF and
the two lines are close and increase in the same proportion,
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67 23h 24.880.8 47 27.7
17.8
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indicating that ultrafiltration is the process dominating calcium component from bath to blood. This diffusive component (from
mass transport. The difference between the two lines is the D—*B) is controlled by the relatively low dialysate flow rate.
diffusive component. In contrast to conventional intermittent Mean calcium loss is 0.39 0.18 mg/mm or 547 mg/day.
hemodialysis, calcium here is uniformly lost from blood due to Calcium loss approaches zero at low (2 to 3 ml/min) ultrafiltra-
the high ultrafiltration rate which overrides the smaller diffusive tion rates.
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I Fig. 11. Relationship of dialysate glucose extraction to dialyzer blood0 2 4 6 8 10 12 14 flow. More rapid blood flow enhances glucose uptake from dialysate to
Qf, cc/mm blood. QDi constant at 16.65 cc/mm.
Fig. 10. Calcium flux JDCa showing the impact of the convective
component (0) on total flux (+).
Table 3. Hydraulic's: Slow continuous hemodialysis
Time
Mean % of to- filter
hydro- Neg. Oncotic Filt — tal TMP used
QBI static LW P— pres- pres- Frac. QB due to before
blood PB, PB0 pres- PRO sure sure mm negative study
TMP QF flow in mm mm sure mm mm mm — Hg/cc! pressure M.A.P. hours! Hct)'
Patient mm/Hg cc/mm cc/mm Hg Hg mm Hg Hg Hg Hg Qpi mm % mm Hg mm in %
L.M. 9.85 156 40 0.086
L.M. 7.95 100 39 0.12
H.A. 11.0 75 34 0.21
H.A. 11.6 90.9 32.5 0.18
CD. 13 180 17 0.10
C.D. 10 180 17 0.076
M.E. 8.75 100 46 0.11
G.D. 5.5 52.5 39.9 0.142
F.C. 11.5 41.0 37 0.44
J.M. 58 5.8 141 64 2 33 62 37 12 0.053 0.43 53
M.P. 53 5.1 58 58 20 39 38 37 23 0.140 0.65 61
L.P. 64 8.75 132 60 32 46 28 40.7 22.5 0.091 0.20 54
L.P. 51 6.2 139 50 10 30 40 40 21 0.063 0.28 68
MW. 8.2 181 11.1 17 0.057
M.W. 4.5 106 2.5 20 0.05
M.B. 53 5.8 127 58 10 34 48 35 16 0.06 0.37 53
M.B. 54 10.2 137 60 10 35 50 35 16 0.10 0.36 57
W.I. 74 3.85 31 40 38 39 2 47.4 12 0.16 0.06 52
R.W. 87 10.6 62 92 60 76 32 44.4 23 0.24 0.51 45
R.W. 84 9.6 66 70 50 60 20 47 23 0.208 0.30 55
R.M. 44 8.2 114 35 10 23 35 34.7 13 0.09 0.30 64
W.P. 36 3.35 146 45 10 27 35 26 17 0.03 0.23 72
Mean 59.8 8.1 109.8 57.4 22.9 40.2 35.4 33.6 18.1 0.13 0.33 57.6
SD ±16.0 ±2.8 ±46.1 ±15,6 ±19.2 ±15.5 ±15.9 ±11.9 ±4.2 ±0.09 ±0.16 ±7.8
N 11 22 22 II 11 11 11 22 13 22 11 11
The dialysate glucose concentration of approximately 1300
mg% is higher than that used in conventional intermittent
hemodialysis, resulting in a significant net uptake of glucose
from bath to blood. Mean glucose extraction from dialysate was
449 13%. Glucose extraction from dialysate to blood is
related to blood flow (Fig. 11). Average net glucose uptake is
107 24.9 mg/mm, or 154 glday equivalent to 616 kcal. When
2.5% glucose dialysate was used, glucose uptake was 188
mg/mm or 270 g/day (one patient).
Hydraulics and ultrafiltration
The hydraulic data relating to ultrafiltration rate are outlined
in Table 3. A borderline correlation is seen between TMP and
QF in the ranges encountered in this study (r 0.52, P = 0.08)
(Fig. 12). In this relatively narrow range of TMP (36 to 87 mm
Hg) and low ultrafiltration rates, a small scatter of ultrafiltration
data points could obscure a true correlation which might be
apparent if a wider range of TMPs were encountered. The
negative pressure, a result of the siphon effect, was a major
determinent of transmembrane pressure. The negative pressure
accounts for 57% of the net TMP in the flat sheet geometry.
Filtration fractions averaged 0.134 0.08 (N = 21) (Table 3).
The relationships between blood flow, and hematocrit versus
ultrafiltration rate were not statistically significant.
Effect of time on dialyzer function
Changes in ultrafiltration rate (QF) with time are shown in
Figure 13. The regression equation relating QF and time is: QF
(cc/mm) = 8.749 — 1.462 (lnt) where t is time (hrs) of use (r =
—0.831, P < 0.001). Ultrafiltration falls to 4.37 cc/mm or one
half of its original value in approximately 20 hours. There is a
rapid fall in QF during the first six hours after which QF declines
minimally for the next 18 hours. Mean ultrafiltration rates for
the entire treatment period of each patient are shown in Table 1.
A total of 2,392 hourly filtration rates were recorded. Since this
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Fig. 12. Ultrafiltration rate QF versus net transmembrane pressure.
Each point is a separate patient study done on different days.
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Fig. 13. Change in ultrafiltration rate with time. Each plotted point is
the group mean 5EM ultrafiltration rate, QF of patients in Table 1,
obtained hourly during a single 24-hour period following use of a new
dialyzer.
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Fig. 14. Changes in total clearance with time in 14 new dialyzers in 9
patients. Each dialyzer is numbered. Five dialyzers had only one
clearance determination indicated by a numbered, circled dot. In these
five dialyzers it is assumed that had earlier clearances been obtained,
they would be no less than the final measurement. When the anomalous
results in dialyzer #3 are omitted from the calculation, mean urea
clearance for 0 to 12 hours is 23.9 2.4 cc/mm. ( = mean SD.
Time, hours of dialyser use
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dialysis technique depends primarily on diffusive transport, the
observed decrease in ultrafiltration rate and hence, convective
clearance is not necessarily considered a major clinical problem.
Total urea clearance in relation to duration of dialyzer use is
seen in Figure 14. Mean urea clearance in 12 dialyzers, com-
puted by averaging 11 studies from the first 12 hours and nine
studies from 13 to 24 hours, was 20.8 3.8 cc/mm. From 13 to
24 hours of use, mean urea clearance was 19.8 2.6 cc/mm (9
dialyzers). From 25 to 50 hours of use, mean urea clearance was
18.5 4 cc/mm (6 dialyzers).
Discussion
The major findings of this study are the exceptionally high,
small molecular—weight clearances obtained in these critically
ill, unstable patients when a pumpless slow, continuous dialysis
technique is used. The mean whole blood urea clearance is 25
4.0 cc/mm. These high clearances are achieved by the small
trickle of dialysis fluid (16 cc/mm or 1 liter/hr) which equili-
brates with dialyzer blood yielding a diffusive clearance of
approximately 16 cc/mm. Added to this is the 8.1 cc/mm mean
convective clearance achieved by ultrafiltration through a highly
water permeable, PAN membrane. Over time the ultrafiltration
rate falls to a mean of 4.8 2.6 cc/mm (Table 1), indicating
some decrease of membrane function with time possibly due to
membrane protein absorption and partial clotting. These clear-
ances are superior to those obtained with standard CAVH (9.5
cc/mm) [4] and equivalent to those using CAVH with suction
and predilution [14, 15]. Also, studies in which the dialysate
flow QDI is doubled to 33 cc/mm result in an almost proportional
increase in diffusive clearance approaching 30 cc/mm. The
increase is not linear because equilibration of blood with
dialysate is not complete [161.
Assuming a whole blood total urea clearance of approxi-
mately 20 cc/mm, consider a hypothetical 70 kg surgical patient
with sepsis and acute renal failure catabolizing 140 grams of
protein per day. Using the relationship G = 0.154 PCR — 1.7
[171, 13.79 mg/mm of urea nitrogen would be produced. An
average urea clearance of 20 cc/mm, if sustained in this patient,
would maintain the BUN at 69 mg%. In contrast, if standard
CAVH were used (clearance of 9.5 cc/mm), the BUN would be
145 mg% with total replacement of filtrate with substitution
fluid.
Interaction of dffiision and convection
In simultaneous dialysis and filtration such as occurs in
intermittent hemodiafiltration, the overall clearance is less than
the sum of the clearances of dialysis and ultrafiltration occur-
ring separately. The reasons for this have been extensively
discussed [18—21]. In the present in vivo studies we were unable
to demonstrate any interaction between diffusive and convec-
tive components of clearance. In Figure 4, the plot of total
clearance minus convective clearance (equal to the diffusive
component) shows no significant change from zero as ultrafil-
tration increases. Although interactions of diffusion and con-
vection may well be present, they are too small to be detected.
Lysaght [22], using an in-vitro low flow, combined filtration and
dialysis system in a 0.25 m2 hollow fiber geometry (Amicon
D-20), has shown a small downward deviation from the theo-
retical maximum at comparable dialysate flow rates. At the
clinical level this apparent lack of interaction allows the diffu-
sive and convective components of clearance to be thought of
as additive.
The combined components of this system, diffusion and
ultrafiltration, lend considerable flexibility to the clinical appli-
cation of this technique. Ultrafiltration and diffusive clearances
can be manipulated separately to achieve maximal or minimal
fluid or solute removal. In patients with average protein cata-
bolic rates, a diffusive clearance of 16 cc/mm alone can maintain
the BUN at an acceptable level. If additional convective solute
clearance is unnecessary, TMP or negative pressure can be
reduced so that ultrafiltration rate simply matches the fluid
intake necessitated by hyperalimentation and i.v. drug admin-
istration. This is analogous to slow continuous ultrafiltration
[22] plus dialysis. The total clearance of urea and similar solutes
can be estimated at the bedside by measuring a timed volume in
the collection bag. Since, in a non-clotting dialyzer, these
studies show that complete diffusion equilibrium occurs, and
since the sieving coefficient is one, the volume of dialysate
outflow will approximate the clearance.
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Appendix 1.
C = Concentration of solute (mg/ml, mEq/ml)B = BloodD = DialysateF = Filtration (cc/mm)J = Flux or mass transfer per unit time (mg/mm;
mEq/min)K = Clearance (cc/mm)P = Pressure mm Hg
Q = Flow rate (cc/mm) such as: QB = blood flow rate;
QD = dialysate flow; QE = effective blood water
flow; and QF = ultrafiltration
= Input, such as: CBI = concentration of blood going
in (mg/mI, mEq/ml)
= Output, such as: QD0 = dialysate flow out (cc/mm)
a = Diffusive component of mass transfer or clearance
= Convective component of mass transfer or clear-
ance
= Plasma
o Staverman's reflection coefficient (0 to 1)
= Osmotic pressure due to membrane permeable spe-
ciesH = Height of column leading to collection bag (cm)
Examples:
KD
KB
KD(d)
= Clearance calculated from dialysate side
= Clearance calculated from blood side
= Diffusive component of clearance calculated
from dialysate side
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KD(C) = Convective component of clearance calculated
from dialysate side
JDCa(c) = Mass transfer dialysate side, convective com-
ponent, such as, for calcium.
Appendix 2.
Computation of effective osmotic pressure exerted by the
dialysis fluid across the PAN membrane requires calculation of
iro- for each solute where 4ir is the osmotic pressure gradient
and if is the Staverman reflection coefficient for that solute in
relation to the PAN membrane. With the exception of glucose,
a- is known to be zero for the non-protein solutes encountered
herein. Since a- for glucose is unreported it is assumed to be
zero. Hence, the effective osmotic pressure exerted by the
dialysis fluid is assumed to be minimal. To the extent that these
assumptions are not accurate, the calculations for effective
osmotic pressure will be inaccurate.
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